tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (TEVA)
NYSE:TEVA
US Market
Advertisement

Teva Pharmaceutical (TEVA) Ownership - Who Owns Teva Pharmaceutical?

Compare
7,605 Followers

Teva Pharmaceutical (TEVA) Ownership Overview

0.41%6.34%19.00%3.89%70.36%
19.00% Other Institutional Investors
3.89% ETFs
70.36% Public Companies and Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail, and individual investors. Approximately 29.23% of the company’s stock is owned by Institutional Investors, 0.41% is owned by Insiders, and 70.36% is owned by Public Companies and Individual Investors.
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail, and individual investors. Approximately 25.34% of the company’s stock is owned by Institutional Investors, 0.41% is owned by Insiders, and 3.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 01, 2025
xxxxxxxxxxxxx
$1301500
Nov 18, 2025
xxxxxxxxxxxxx
$753300
Nov 10, 2025
xxxxxxxxxxxxx
$4820000
Nov 10, 2025
xxxxxxxxxxxxx
$300489

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$1378084
Sep 30, 2025
xxxxxxxxxxxxx
$2398164
Sep 30, 2025
xxxxxxxxxxxxx
$3336979
Sep 30, 2025
xxxxxxxxxxxxx
$10100000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
28,521,445Institution2.49%716,743,913
20,775,307Institution1.81%522,083,465
15,968,935Institution1.39%401,299,337
15,824,223Institution1.38%397,662,724
11,681,333Institution1.02%293,551,898
8,289,998Institution0.72%208,327,650
4,377,690Institution0.38%110,011,350
4,345,490Institution0.38%109,202,164
4,257,115Institution0.37%106,981,300
4,208,741Institution0.37%105,765,661

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
20,775,307Institution1.81%522,083,465
4,345,490Institution0.38%109,202,164
4,257,115Institution0.37%106,981,300
4,176,528Institution0.36%104,956,149
3,711,397Institution0.32%93,267,407
3,474,986Institution0.30%87,326,398
3,041,600Institution0.27%76,435,408
2,894,900Institution0.25%72,748,837
2,697,844Institution0.24%67,796,820
2,501,010Institution0.22%62,850,381

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,774,225Institution0.68%186,348,173
3,930,257Institution0.34%94,208,260
2,019,551Institution0.18%48,408,637
1,692,681Institution0.15%43,721,950
1,664,198Institution0.15%41,821,296
1,664,198Institution0.15%41,821,296
1,598,099Institution0.14%38,306,433
1,189,811Institution0.10%29,899,950
1,039,358Institution0.09%24,913,411
897,321Institution0.08%22,549,677

FAQ

Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 19.00% of the company's stock is held by institutional investors, 0.41% is held by insiders, and 70.36% is held by retail investors.
    What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 19.00% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
      What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 70.36% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
        Who owns the most shares of Teva Pharmaceutical (TEVA)?
        iShares owns the most shares of Teva Pharmaceutical (TEVA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis